Indiana COVID-19 hospitalizations fall below 3,000
The state on Saturday reported 73 more deaths due to COVID-19, the 10th time deaths have exceeded 70 in the past 12 daily reports.
The state on Saturday reported 73 more deaths due to COVID-19, the 10th time deaths have exceeded 70 in the past 12 daily reports.
Much-needed doses are set to arrive Monday after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health.
Red tape, staff shortages, testing delays and strong skepticism are keeping many patients and doctors from the drugs made by Eli Lilly and Co. and Regeneron Pharmaceuticals.
The Food and Drug Administration was evaluating a shot developed by Moderna Inc. and the National Institutes of Health and was expected to give it the green light soon, clearing the way for its use to begin as early as Monday.
Sen. John Thune, R-S.D., the No. 2 Senate Republican, told reporters Friday afternoon that expectations of a deal by the end of the day reflected “a triumph of hope over experience.”
As the coronavirus sidelines huge numbers of educators, school districts are turning to college students, who are learning online or home for extended winter breaks.
The suit alleges the governor’s executive order is unconstitutional and caused “unjust injury to [the restaurant’s] fundamental civil rights, liberty interests and property rights.”
The state on Friday reported 84 more deaths due to COVID-19, the ninth time deaths have exceeded 70 in the past 11 daily reports.
Vice President Mike Pence became the highest ranking U.S. official to receive the first dose of the COVID-19 vaccine on Friday in a live-television event aimed at reassuring Americans the shot is safe.
Bearing down on a midnight shutdown deadline, top negotiators on a must-pass, almost $1 trillion COVID-19 economic relief package are committed to sealing an agreement Friday as they resolve remaining differences.
Once FDA’s emergency use authorization is granted, Moderna will begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
U.S. stocks notched solid gains Thursday to close at all-time highs, even as lawmakers continue to wrangle over a federal spending deal.
The pending bill is the first significant legislative response to the pandemic since the landmark CARES Act passed virtually unanimously in March, delivering $1.8 trillion in aid.
The state reported 79 more deaths due to COVID-19, the eighth time deaths have exceeded 70 in the past 10 reports.
Nationally, the total number of people who are receiving traditional state unemployment benefits fell to 5.5 million from 5.8 million. That figure is down sharply from its peak of nearly 23 million in May.
The Food and Drug Administration said Wednesday that pharmacists can draw additional doses from vials of the Pfizer coronavirus vaccine, potentially expanding the country’s supply by millions of doses.
Allergies are always a question with a new medical product, but monitoring COVID-19 vaccines for any other, unexpected side effects is a bigger challenge than usual.
In a mixed and muted day of trading, the S&P 500 rose 6.55 points, or 0.2%, to 3,701.17. It’s within roughly 1 point of its record set last week.
The package emerging is expected to include hundreds of billions of dollars in aid for ailing small businesses and jobless Americans and a one-time check of between $600 and $700 for millions of Americans below a certain income threshold.
U.S. officials say they’re actively negotiating for additional purchases of Pfizer’s coronavirus vaccine after passing up a chance to lock in a contract this summer since it was still unclear how well the shots would work.